This is the first study to measure peripheral CRP with the same high-sensitivity assay across a large sample of patients with MDD (n = 198) prospectively stratified in terms of their current and past history of treatment with monoaminergic antidepressant drugs. Here, CRP is linked to major depressive disorder.